Inhibikase Therapeutics Inc
NASDAQ:IKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
US |
|
B
|
Briscoe Group Ltd
ASX:BGP
|
NZ |
|
Equitable Group Inc
TSX:EQB
|
CA |
|
M
|
MNRB Holdings Bhd
KLSE:MNRB
|
MY |
|
Bexcellent Group Holdings Ltd
HKEX:1775
|
HK |
|
GMO Pepabo Inc
TSE:3633
|
JP |
|
P
|
PENN Entertainment Inc
SWB:PN1
|
US |
|
Gene Biotherapeutics Inc
OTC:CRXM
|
US |
|
Bpost SA
XBRU:BPOST
|
BE |
|
R
|
Roquefort Therapeutics PLC
LSE:ROQ
|
UK |
|
Transcoal Pacific Tbk PT
IDX:TCPI
|
ID |
|
T
|
Teikoku Sen-I Co Ltd
TSE:3302
|
JP |
|
S
|
Svenska Aerogel Holding AB (publ)
STO:AERO
|
SE |
|
Fairwood Holdings Ltd
HKEX:52
|
HK |
|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
US |
|
Tsubakimoto Kogyo Co Ltd
TSE:8052
|
JP |
|
P
|
Procorp SAB de CV
BMV:PROCORPB
|
MX |
Bankruptcy Probability
Inhibikase Therapeutics Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Inhibikase Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
191.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Inhibikase Therapeutics Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Inhibikase Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
